Yamo Pharmaceuticals Enrolls Final Patient in Phase 2 Study Evaluating L1-79 to Treat the Core Symptoms of Autism Spectrum Disorder tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Within venture capital, a new sector is emerging driving innovation in autism diagnosis, therapies and therapeutics. Given the demographics of autism and markets, these funds will grow and others emerge in the next few years.
/PRNewswire/ The autism spectrum disorder therapeutics market is set to grow by USD 772.65 million from 2022 to 2027, progressing at a CAGR of 7.2% during.